Picture of Sun Pharma Advanced Research logo

SPARC — Sun Pharma Advanced Research News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

India's Sun Pharma Advanced Research slumps 15% after drug fails mid-stage study

** Shares of Sun Pharma Advanced Research SPRC.NS down 15% at 166 rupees, marking worst pct drop since March 2020
** Co on Tuesday said its partner informed that a drug treating psoriasis did not meet main goal in mid-stage study
** Including session's drop, SPRC down 16% YTD

 (Reporting by Sethuraman NR in Bengaluru)

 ((Sethuraman.NR@thomsonreuters.com; (+91 9945291420); Reuters Messaging: nallur.sethuraman.thomsonreuters.com@reuters.net ))

Recent news on Sun Pharma Advanced Research

See all news